Viewing Study NCT06239532


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2025-12-25 @ 7:33 PM
Study NCT ID: NCT06239532
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-21
First Post: 2023-12-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma
Sponsor:
Organization: